Prothena Corp plc 4
4 · Prothena Corp plc · Filed Feb 6, 2014
Insider Transaction Report
Form 4
Koller Martin
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2014-02-04+40,000→ 40,000 totalExercise: $29.81Exp: 2024-02-04→ Ordinary Shares (40,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 4, 2015 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.